CSIMarket
 


Idexx Laboratories Inc  (IDXX)
Other Ticker:  
 

Idexx Laboratories Inc's Leverage Ratio

IDXX's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -0.76% Idexx Laboratories Inc improved Leverage Ratio in forth quarter 2023 to 1.2, below the company's average Leverage Ratio.

Within In Vitro & In Vivo Diagnostic Substances industry in the forth quarter 2023, 3 other companies have achieved lower Leverage Ratio than Idexx Laboratories Inc in the IV Quarter 2023. While Leverage Ratio total ranking has improved so far in the forth quarter 2023 to 1357, from total ranking in the third quarter 2023 at 2388 .

Explain Leverage Ratio?
Who are IDXX Customers?
What are IDXX´s Total Liabilities?


IDXX Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change 143.87 % 172.57 % 139.35 % 31.46 % -11.78 %
Y / Y Total Liabilities Change -16.96 % -15.74 % -15.76 % 2.89 % 22.37 %
Leverage Ratio MRQ 1.2 1.38 1.62 2.34 3.51
IDXX's Total Ranking # 1357 # 2388 # 2724 # 3277 # 3968
Seq. Equity Change 14.42 % 18.61 % 30.05 % 38.17 % 27.89 %
Seq. Total Liabilities Change -0.76 % 0.68 % -9.68 % -7.99 % 0.7 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 4
Healthcare Sector # 314
Overall Market # 1355


Leverage Ratio Statistics
High Average Low
171.78 10.6 0.73
(Jun 30 2015)   (Dec 31 2012)




Financial Statements
Idexx Laboratories Inc's Equity $ 1,485 Millions Visit IDXX's Balance sheet
Idexx Laboratories Inc's Total Liabilities $ 1,775 Millions Visit IDXX's Balance sheet
Source of IDXX's Sales Visit IDXX's Sales by Geography


Cumulative Idexx Laboratories Inc's Leverage Ratio

IDXX's Leverage Ratio for the trailling 12 Months

IDXX Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth 143.87 % 172.57 % 139.35 % 31.46 % -11.78 %
Y / Y Total Liabilities TTM Growth -16.96 % -15.74 % -15.76 % 2.89 % 22.37 %
Leverage Ratio TTM 1.55 2 2.65 3.5 3.8
Total Ranking TTM # 4 # 109 # 154 # 37 # 3366
Seq. Equity TTM Growth 14.42 % 18.61 % 30.05 % 38.17 % 27.89 %
Seq. Total Liabilities TTM Growth -0.76 % 0.68 % -9.68 % -7.99 % 0.7 %


On the trailing twelve months basis Due to repayements of liabilities of -0.76% Idexx Laboratories Inc decreased Leverage Ratio in the 12 months ending in IV Quarter 2023 to 1.55, below the company's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the In Vitro & In Vivo Diagnostic Substances industry IDXX recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 4, from total ranking in previous 12 month period at 109.

Explain Leverage Ratio?
Who are IDXX Customers?
What are IDXX´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the In Vitro & In Vivo Diagnostic Substances Industry # 0
Healthcare Sector # 1
Within the Market # 4


trailing twelve months Leverage Ratio Statistics
High Average Low
14783.78 442.82 1.11
(Mar 31 2019)   (Dec 31 2013)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within In Vitro & In Vivo Diagnostic Substances Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity
Idexx Laboratories Inc  1.20 $ 1,775.395  Millions$ 1,484.530  Millions
Lantheus Holdings Inc   1.02 $ 835.257  Millions$ 815.892  Millions
Myriad Genetics Inc   0.46 $ 363.300  Millions$ 783.200  Millions
Biomerica Inc   0.26 $ 2.448  Millions$ 9.383  Millions

Date modified: 2024-02-23T14:03:56+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com